Quanterix Corporation (QTRX)
NASDAQ: QTRX
· Real-Time Price · USD
5.54
0.11 (2.03%)
At close: Oct 01, 2025, 3:59 PM
5.62
1.44%
Pre-market: Oct 02, 2025, 08:00 AM EDT
2.03% (1D)
Bid | 5.05 |
Market Cap | 257.42M |
Revenue (ttm) | 125.38M |
Net Income (ttm) | -70.5M |
EPS (ttm) | -1.89 |
PE Ratio (ttm) | -2.93 |
Forward PE | -4.34 |
Analyst | Hold |
Dividends | n/a |
Ask | 5.7 |
Volume | 416,066 |
Avg. Volume (20D) | 660,963 |
Open | 5.42 |
Previous Close | 5.43 |
Day's Range | 5.37 - 5.64 |
52-Week Range | 4.05 - 15.67 |
Beta | 1.03 |
Ex-Dividend Date | n/a |
About QTRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol QTRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for QTRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsQuanterix Corporation is scheduled to release its earnings on
Nov 11, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
6 months ago
-1.79%
Quanterix Corporation shares are trading lower aft...
Unlock content with
Pro Subscription
10 months ago
-18.26%
Quanterix shares are trading lower. The company reported Q3 financial results.

1 month ago · businesswire.com
Quanterix to Present at the Canaccord Genuity 45th Annual Growth ConferenceBILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that its executive leadershi...

2 months ago · businesswire.com
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announ...